MetLife Inc (MET)
Official siteFINANCIAL SERVICES • INSURANCE - LIFE • NYSE
Market Cap: $64.51B
Last updated: Nov 17, 2026 at 11:06 AM ET
MetLife Inc (MET) Earnings: Report Dates and Results
MetLife (MET) is expected to report earnings on Feb 2, 2027. In the quarter ended Sep 30, 2026, MetLife reported EPS of $2.85, above the $2.71 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
MET has an expected report date of Feb 2, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 6.4% above the $2.49 reported for the quarter ended Dec 31, 2025.
MET Earnings Call
The latest MET earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, MET beat 29, missed 10 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $20.84B, up 18.3% from $17.62B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $2.85 | $2.71 | $2.62 - $2.92 | +5.17% | Beat | +21.8% | 16 | 14 up, 0 down | Nov 4, 2026 | $20.84B |
| Jun 30, 2026 | $2.43 | $2.30 | $2.20 - $2.40 | +5.65% | Beat | +20.3% | 15 | 2 up, 12 down | Aug 5, 2026 | $19.42B |
| Mar 31, 2026 | $2.42 | $2.27 | $2.16 - $2.38 | +6.61% | Beat | +23.5% | 16 | 11 up, 3 down | May 6, 2026 | $18.95B |
| Dec 31, 2025 | $2.49 | $2.34 | $2.26 - $2.41 | +6.41% | Beat | +19.1% | 14 | 3 up, 6 down | Feb 4, 2026 | $24.05B |
| Sep 30, 2025 | $2.34 | $2.33 | $2.24 - $2.51 | +0.43% | Beat | +20.0% | 15 | 9 up, 4 down | Nov 5, 2025 | $17.62B |
| Jun 30, 2025 | $2.02 | $2.16 | $2.02 - $2.45 | -6.48% | Miss | -11.4% | 13 | 0 up, 11 down | Aug 6, 2025 | $17.62B |
| Mar 31, 2025 | $1.96 | $2.01 | $1.96 - $2.05 | -2.49% | Miss | +7.1% | 13 | 0 up, 11 down | Apr 30, 2025 | $18.27B |
| Dec 31, 2024 | $2.09 | $2.09 | $1.96 - $2.25 | 0.00% | In line | +14.2% | 13 | 1 up, 7 down | Feb 5, 2025 | $18.50B |
| Sep 30, 2024 | $1.95 | $2.18 | $1.98 - $2.42 | -10.55% | Miss | -1.0% | 14 | 2 up, 0 down | Oct 30, 2024 | $17.91B |
| Jun 30, 2024 | $2.28 | $2.11 | $2.01 - $2.22 | +8.06% | Beat | +17.5% | 13 | 3 up, 0 down | Jul 31, 2024 | $17.82B |
| Mar 31, 2024 | $1.83 | $1.82 | $1.64 - $1.93 | +0.55% | Beat | +20.4% | 12 | 0 up, 2 down | May 1, 2024 | $16.75B |
| Dec 31, 2023 | $1.83 | $1.91 | $1.73 - $2.09 | -4.19% | Miss | +18.1% | 14 | 2 up, 2 down | Jan 31, 2024 | $20.21B |
| Sep 30, 2023 | $1.97 | $1.96 | $1.80 - $2.20 | +0.51% | Beat | +62.8% | 12 | 2 up, 1 down | Nov 1, 2023 | $15.87B |
| Jun 30, 2023 | $1.94 | $1.88 | $1.65 - $2.08 | +3.19% | Beat | -3.0% | 13 | 1 up, 1 down | Aug 2, 2023 | $16.62B |
| Mar 31, 2023 | $1.52 | $1.84 | $1.57 - $2.08 | -17.39% | Miss | -26.9% | 15 | 2 up, 1 down | May 3, 2023 | $15.20B |
| Dec 31, 2022 | $1.55 | $1.64 | $1.41 - $1.88 | -5.49% | Miss | -28.6% | 16 | 2 up, 1 down | Feb 1, 2023 | $17.84B |
| Sep 30, 2022 | $1.21 | $1.17 | $0.74 - $1.67 | +3.42% | Beat | -49.4% | 16 | 1 up, 1 down | Nov 2, 2022 | $22.28B |
| Jun 30, 2022 | $2.00 | $1.48 | $0.81 - $1.80 | +35.14% | Beat | -13.0% | 15 | 1 up, 1 down | Aug 3, 2022 | $15.47B |
| Mar 31, 2022 | $2.08 | $1.63 | $1.35 - $1.89 | +27.61% | Beat | -5.5% | 14 | 5 up, 0 down | May 4, 2022 | $16.84B |
| Dec 31, 2021 | $2.17 | $1.46 | $1.04 - $2.19 | +48.63% | Beat | +6.9% | 15 | N/A | Feb 2, 2022 | $17.70B |
| Sep 30, 2021 | $2.39 | $1.71 | $1.54 - $1.82 | +39.77% | Beat | +38.2% | 12 | 4 up, 0 down | Nov 3, 2021 | $16.91B |
| Jun 30, 2021 | $2.30 | $1.66 | $1.51 - $1.95 | +38.55% | Beat | +177.1% | 13 | N/A | Aug 4, 2021 | $18.52B |
| Mar 31, 2021 | $2.20 | $1.52 | $1.43 - $1.70 | +44.74% | Beat | +39.2% | 14 | N/A | May 5, 2021 | $15.56B |
| Dec 31, 2020 | $2.03 | $1.51 | $1.36 - $1.67 | +34.44% | Beat | +2.5% | 13 | N/A | Feb 3, 2021 | $19.42B |
| Sep 30, 2020 | $1.73 | $1.58 | $1.40 - $1.93 | +9.49% | Beat | +36.2% | 11 | N/A | Nov 4, 2020 | $16.02B |
| Jun 30, 2020 | $0.83 | $0.91 | $0.73 - $1.15 | -8.79% | Miss | -39.9% | 11 | N/A | Aug 5, 2020 | $14.10B |
| Mar 31, 2020 | $1.58 | $1.44 | $1.31 - $1.51 | +9.72% | Beat | +6.8% | 14 | N/A | May 6, 2020 | $18.31B |
| Dec 31, 2019 | $1.98 | $1.38 | $1.32 - $1.45 | +43.48% | Beat | +46.7% | 15 | N/A | Feb 5, 2020 | $17.14B |
| Sep 30, 2019 | $1.27 | $1.40 | $1.35 - $1.42 | -9.29% | Miss | -8.0% | 18 | N/A | Oct 30, 2019 | $18.68B |
| Jun 30, 2019 | $1.38 | $1.34 | $1.25 - $1.40 | +2.99% | Beat | +6.2% | 18 | N/A | Jul 31, 2019 | $17.50B |
| Mar 31, 2019 | $1.48 | $1.27 | $1.09 - $1.35 | +16.54% | Beat | +8.8% | 18 | N/A | May 1, 2019 | $16.30B |
| Dec 31, 2018 | $1.35 | $1.29 | $1.17 - $1.34 | +4.65% | Beat | +110.9% | 18 | N/A | Feb 6, 2019 | $15.66B |
| Sep 30, 2018 | $1.38 | $1.26 | $1.21 - $1.33 | +9.52% | Beat | +26.6% | 18 | N/A | Nov 1, 2018 | $16.29B |
| Jun 30, 2018 | $1.30 | $1.17 | $1.12 - $1.24 | +11.11% | Beat | 0.0% | 18 | N/A | Aug 1, 2018 | $21.18B |
| Mar 31, 2018 | $1.36 | $1.17 | $1.10 - $1.22 | +16.24% | Beat | -3.5% | 18 | N/A | May 2, 2018 | $14.80B |
| Dec 31, 2017 | $0.64 | $0.65 | $0.62 - $1.13 | -1.54% | Miss | -50.0% | 16 | N/A | Feb 13, 2018 | $15.84B |
| Sep 30, 2017 | $1.09 | $0.92 | $0.82 - $1.05 | +18.48% | Beat | -14.8% | 15 | N/A | Nov 1, 2017 | $16.17B |
| Jun 30, 2017 | $1.30 | $1.28 | $1.25 - $1.33 | +1.56% | Beat | +56.6% | 16 | N/A | Aug 2, 2017 | $15.33B |
| Mar 31, 2017 | $1.41 | $1.28 | N/A | +10.16% | Beat | +17.5% | N/A | N/A | May 3, 2017 | $14.96B |
| Dec 31, 2016 | $1.28 | $1.34 | N/A | -4.48% | Miss | +4.1% | N/A | N/A | Feb 1, 2017 | $11.26B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $8.81, up 8.1% from the year before. It was $4.59 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $8.81 | +8.1% |
| Dec 31, 2024 | $8.15 | +12.3% |
| Dec 31, 2023 | $7.26 | +6.1% |
| Dec 31, 2022 | $6.84 | -24.5% |
| Dec 31, 2021 | $9.06 | +46.8% |
| Dec 31, 2020 | $6.17 | +1.0% |
| Dec 31, 2019 | $6.11 | +13.4% |
| Dec 31, 2018 | $5.39 | +21.4% |
| Dec 31, 2017 | $4.44 | -3.3% |
| Dec 31, 2016 | $4.59 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,000 words across 13 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,040 | 13 | |
| 2026Q2 | Jun 30, 2026 | 7,031 | 13 | |
| 2026Q1 | Mar 31, 2026 | 6,911 | 13 | |
| 2025Q4 | Dec 31, 2025 | 7,150 | 12 | |
| 2025Q3 | Sep 30, 2025 | 7,211 | 15 | |
| 2025Q2 | Jun 30, 2025 | 7,793 | 15 | |
| 2025Q1 | Mar 31, 2025 | 8,330 | 14 | |
| 2024Q4 | Dec 31, 2024 | 8,786 | 13 |
2026Q3 Earnings Call
Opening remarks
John Hall Treasurer and Global Head of Investor Relations Thank you, operator, and good morning, everyone. Welcome to MetLife's Third Quarter 2026 Earnings Call. Before we begin, please review the information on non-GAAP measures in our earnings release, in our quarterly financial supplement and in our earnings call and investor presentations, all of which can be found on the Investor Relations website at metlife.com. On the call today are Michel Khalaf, President and Chief Executive Officer; and John McCallion, Chief Financial Officer and Head of MetLife Investment Management. Other members of senior management are also available to participate. This morning, John will speak to the earnings call presentation we released last night on our website. An appendix to the deck features disclosures, GAAP reconciliations and other information, which you should review. After prepared remarks, we will have a Q&A session that ends at the top of the hour. As a reminder, please limit yourself to 1 question and 1 follow-up. Now to Michel.
Michel Khalaf President and Chief Executive Officer Thank you, John, and good morning, everyone. The third quarter was another excellent quarter under our New Frontier strategy. We delivered MetLife's highest adjusted earnings per share quarter ever with top line growth across all operating segments. More importantly, the quarter extends the pattern we have demonstrated throughout the year: broad-based growth, attractive returns and disciplined capital management. Variable investment income was a significant contributor this quarter, particularly through private equity and venture capital returns. While VII amplified the quarter, it did not define it. We also delivered strong underwriting and volume growth across the enterprise. No single business drove results. That breadth is the central strength of MetLife. Our complementary capital-light and capital-driven earnings engines allow us to create value in different ways and across different market environments. Underwriting margins, fees and spread income generate durable earnings and recurring cash flow. We reinvest that cash where MetLife has structural advantages and return excess capital to shareholders. The engines also reinforce one another. Our retirement businesses originate liabilities backed by long-term assets, and we use insurance and third-party capital to support that growth. MetLife Investment Management manages most of the assets, adding fee income and expanding our capital-light earnings. This efficient model helps fuel growth and generate capital to reinvest. It is a model designed to compound. Two years into New Frontier, the evidence that the strategy is working as intended is increasingly clear. Year-to-date, adjusted earnings per share, excluding notable items, are up 22%, with adjusted return on equity above 17%. The sources of growth vary from quarter to quarter, but the pattern is consistent: broad-based execution, attractive returns and strong cash generation. Now to the third quarter numbers. We reported adjusted earnings of $1.8 billion, or $2.78 per share.
Frequently Asked Questions About MET
When is MetLife's next earnings date?
MetLife's next earnings report is expected for Feb 2, 2027.
Did MET beat earnings estimates last quarter?
Yes. MetLife reported EPS of $2.85 for the quarter ended Sep 30, 2026, above the $2.71 estimate, a 5.17% surprise.
What EPS do analysts expect from MET next quarter?
The consensus EPS estimate for MetLife for the quarter ending Dec 31, 2026 is $2.65 from 18 analysts, with estimates from $2.36 to $3.00.
How often does MET beat earnings estimates?
MetLife beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +1.91%.
MET pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts